ACROBIOSYSTEMS CO.,LTD. — Investor Relations & Filings
ACROBIOSYSTEMS CO.,LTD. is a global biotechnology company specializing in the development and manufacturing of high-quality recombinant proteins and critical reagents for the life sciences industry. The company provides a comprehensive portfolio of products designed to accelerate the development of target therapeutics, including antibodies, cell and gene therapies, and vaccines. Key offerings include a wide range of biotinylated proteins, enzymes, and assay kits characterized by high bioactivity and batch-to-batch consistency. ACROBIOSYSTEMS supports drug discovery and clinical development through specialized platforms for protein engineering and characterization. Its products serve a diverse client base of pharmaceutical companies, biotechnology firms, and academic research institutions worldwide, focusing on therapeutic areas such as oncology, immunology, and infectious diseases.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 关于回购专用证券账户股份注销完成暨股份变动的公告 | 2025-12-04 | Chinese | |
| 招商证券股份有限公司关于北京百普赛斯生物科技股份有限公司延长部分募集资金投资项目实施期限的核查意见 | 2025-12-01 | Chinese | |
| 关于延长部分募集资金投资项目实施期限的公告 | 2025-12-01 | Chinese | |
| 关于使用剩余超募资金永久补充流动资金的公告 | 2025-12-01 | Chinese | |
| 招商证券股份有限公司关于北京百普赛斯生物科技股份有限公司使用剩余超募资金永久补充流动资金的核查意见 | 2025-12-01 | Chinese | |
| 第二届董事会第二十三次会议决议公告 | 2025-12-01 | Chinese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2025
15 filings
| |||||
| 44581531 | 关于回购专用证券账户股份注销完成暨股份变动的公告 | 2025-12-04 | Chinese | ||
| 44581522 | 招商证券股份有限公司关于北京百普赛斯生物科技股份有限公司延长部分募集资金投资项目实施期限的核查意见 | 2025-12-01 | Chinese | ||
| 44581515 | 关于延长部分募集资金投资项目实施期限的公告 | 2025-12-01 | Chinese | ||
| 44581497 | 关于使用剩余超募资金永久补充流动资金的公告 | 2025-12-01 | Chinese | ||
| 44581482 | 招商证券股份有限公司关于北京百普赛斯生物科技股份有限公司使用剩余超募资金永久补充流动资金的核查意见 | 2025-12-01 | Chinese | ||
| 44581463 | 第二届董事会第二十三次会议决议公告 | 2025-12-01 | Chinese | ||
| 44581450 | 关于召开2025年第五次临时股东会的通知 | 2025-12-01 | Chinese | ||
| 44581436 | 关于续聘2025年度审计机构的公告 | 2025-12-01 | Chinese | ||
| 44581424 | 关于减少注册资本暨通知债权人的公告 | 2025-11-13 | Chinese | ||
| 44581410 | 2025年第四次临时股东会决议公告 | 2025-11-13 | Chinese | ||
| 44581392 | 上海市通力律师事务所关于北京百普赛斯生物科技股份有限公司2025年第四次临时股东会的法律意见书 | 2025-11-13 | Chinese | ||
| 44581370 | 关于召开2025年第四次临时股东会的提示性公告 | 2025-11-07 | Chinese | ||
| 44581357 | 关于减少注册资本暨修订《公司章程》的公告 | 2025-10-28 | Chinese | ||
| 44581348 | 关于2025年三季度计提资产减值损失和信用减值损失的公告 | 2025-10-28 | Chinese | ||
| 44581324 | 关于授权公司管理层启动公司境外发行股份（H股）并在香港联合交易所有限公司上市相关筹备工作的提示性公告 | 2025-10-28 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
1NKEMIA
Biotechnology company providing R&D and services for the li…
|
IKM | ES | Professional, scientific and te… |
|
2cureX AB
Develops an IVD test using 3D tumoroids to predict patient …
|
2CUREX | SE | Professional, scientific and te… |
|
Abattis Bioceuticals Corp.
Life sciences company aggregating and investing in cannabis…
|
ATTBF | CA | Professional, scientific and te… |
|
Abera Bioscience AB
Develops mucosal vaccines using a proprietary Outer Membran…
|
ABERA | SE | Professional, scientific and te… |
|
ABION Inc.
Clinical-stage biopharma developing therapeutics for oncolo…
|
203400 | KR | Professional, scientific and te… |
|
ABL Bio Inc.
Develops bispecific antibody therapeutics for oncology and …
|
298380 | KR | Professional, scientific and te… |
|
Abnova (Taiwan) Corporation
Global leader in high-throughput production of antibodies a…
|
4133 | TW | Professional, scientific and te… |
|
Abpro Holdings, Inc.
Clinical-stage biotech developing antibody therapeutics for…
|
ABP | US | Professional, scientific and te… |
|
Absci Corp
A generative AI drug creation company developing biologic m…
|
ABSI | US | Professional, scientific and te… |
|
Achiko AG
A digital services platform for cross-border business compl…
|
ACHI | CH | Professional, scientific and te… |
ACROBIOSYSTEMS CO.,LTD. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/56034/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=56034 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=56034 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=56034 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 56034}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for ACROBIOSYSTEMS CO.,LTD. (id: 56034)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.